A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants
Condition:   Healthy Volunteers Interventions:   Drug: BMS-986419;   Drug: Caffeine;   Drug: Bupropion;   Drug: Flurbiprofen;   Drug: Omeprazole;   Drug: Midazolam;   Drug: Fexofenadine Sponsor:   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2023 Category: Research Source Type: clinical trials